Cardiovascular events are the primary cause of mortality in patients with obstructive sleep
apnea and obesity. The rising prevalence of obstructive sleep apnea in recent decades has …

To the Editor The systematic review and meta-analysis by Dr Yu and colleagues1 examined
associations of positive airway pressure (PAP) therapy with cardiovascular events and death …

Background: Obstructive sleep apnea is a highly prevalent disorder often treated with
continuous positive airway pressure (CPAP). CPAP transmits high pressures through the …

Die obstruktive Schlafapnoe (OSA) kann zu einer erheblichen Einschränkung der
Lebensqualität führen, und eine nicht behandelte mittel-bis schwergradige OSA (Apnoe …

Study Objectives: It has been suggested that treatment for obstructive sleep apnea (OSA)
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …

Background: After the publication of the Japanese Circulation Society guideline of sleep-
disordered breathing (SDB) in 2010, with new evidence and changes to the health …

The Development of New Interventional Clinical Trials on Obstructive Sleep Apnoea: Targeting
the Outcome, Endotype and Trial Design The Development of New Interventional Clinical …

Objective To compare the cardio-and cerebrovascular outcomes and survival rates of
surgical and nonsurgical interventions for patients with obstructive sleep apnea (OSA) …

Objective Obstructive sleep apnea (OSA) is a major public health problem of pandemic
proportions. In-laboratory OSA diagnosis and continuous positive airway pressure (CPAP) …

Background and objective Obstructive sleep apnoea (OSA) is a prevalent sleep disorder
associated with increased cardiovascular morbidity and mortality. Whether treatment of OSA …